-

Salesforce’s Agentforce Life Sciences Selected by Novartis to Drive More Personalized Customer Engagement Globally

SAN FRANCISCO--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world’s #1 AI CRM, announced today that Novartis (NYSE: NVS), a leading global innovative medicines company, has selected Salesforce’s Agentforce Life Sciences for Customer Engagement to connect patient and healthcare professional (HCP) experiences, enabling teams to focus on strategic and meaningful customer interactions. Building upon its existing investments with Agentforce Health, Data 360 for Health & Life Sciences, MuleSoft for Life Sciences and Agentforce Marketing, Novartis plans to unify engagement across marketing, sales, patient services, medical, market access, and other service stakeholders to drive more cohesive, intelligent healthcare touchpoints.

Novartis plans to roll out Salesforce’s Agentforce 360 for Life Sciences platform globally over the next five years, with the goal of radically simplifying orchestration and experiences across its teams. The platform will allow them to become more integrated around the customer, with compliance capabilities and customer insights embedded directly through AI and data harmonization.

"The expanded partnership with Novartis underscores our commitment to transforming how the life sciences industry engages with marketing, sales, and medical stakeholders," said Frank Defesche, General Manager of Life Sciences at Salesforce. "By unifying engagement on Agentforce Life Sciences, we're providing the foundation for more personal, accurate, and connected experiences. This collaboration is ultimately about getting the right therapies to the patients that need them."

Learn more:

About Salesforce

Salesforce helps organizations of any size become agentic enterprises — integrating humans, agents, apps, and data on a trusted, unified platform to unlock unprecedented growth and innovation. Visit www.salesforce.com for more information.

Any unreleased services or features referenced here are not currently available and may not be delivered on time or at all. Customers should make their purchase decisions based upon features that are currently available.

Contacts

Maha Neouchy
Salesforce
Public Relations
408-568-8442
pr@salesforce.com

Salesforce

NYSE:CRM

Release Versions

Contacts

Maha Neouchy
Salesforce
Public Relations
408-568-8442
pr@salesforce.com

More News From Salesforce

Salesforce's Agentforce 360 Powers the Future of Chess with FIDE

SAN FRANCISCO & LAUSANNE, Switzerland--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the #1 AI CRM, today announced a landmark multiyear partnership with the International Chess Federation (FIDE), becoming the Title Sponsor of the FIDE World Championship Matches 2026–28 and the official AI partner of the FIDE World Chess Championship and FIDE Rankings. The collaboration will utilize the full power of Agentforce 360 — the complete portfolio of Salesforce AI solutions that power the Agentic Enterprise...

Salesforce Completes Acquisition of Fin

SAN FRANCISCO--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world’s #1 AI CRM, today announced it has completed its acquisition of Fin, formerly Intercom, an industry-leading customer agent company. The close of the acquisition brings Fin’s customer agent platform and world-class technical AI team to Salesforce, along with an established global customer base of more than 30,000 companies. Powered by the Fin model suite, the company’s proprietary AI models trained specifically for customer exper...

Salesforce Announces Quarterly Dividend

SAN FRANCISCO--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world’s #1 AI CRM, today announced that its board of directors declared a quarterly cash dividend of $0.44 per share. The dividend is payable October 8, 2026 to shareholders of record on September 17, 2026. About Salesforce Salesforce helps organizations of any size become Agentic Enterprises — integrating humans, agents, apps, and data on a trusted, unified platform to unlock unprecedented growth and innovation. Visit www.salesforce.c...
Back to Newsroom